Get started
Author

Paola Deambrosis

Observed names: DEAMBROSIS, PAOLA, P. DEAMBROSIS, P. Deambrosis, Paola De Ambrosis
Institution: Regione del Veneto
ORCID: 0009-0009-8179-4052
Observed ORCIDs: 0009-0009-8179-4052, 0000-0001-7946-2459
OpenAlex ID: A5004398505
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health
2024 · Carlotta Lunghi, Maria Rosa Valetto, et al. · Drug Safety · 47
PDF
Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994–2003
2007 · Paola Deambrosis, Cristina Saramin, et al. · European Journal of Clinical Pharmacology · 45
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project
2021 · Gianluca Trifirò, Valentina Isgrò, et al. · BioDrugs · 42
New oral anti-coagulants versus vitamin K antagonists in high thromboembolic risk patients
2019 · Annachiara Bellin, Patrizia Berto, et al. · PLoS ONE · 21
PDF
Antimicrobial Stewardship and Infection Prevention and Control in the Veneto Region, Northeastern Italy: Governance Models, Resources, and Key Challenges Across Hospital and Community Settings—Findings from the ARCO Project
2025 · Paola Anello, Stefano Vianello, et al. · Microorganisms · 20
PDF
Antidepressant Drug Prescribing Patterns to Outpatients of an Italian Local Health Authority During the Years 1998 to 2008
2010 · Paola Deambrosis, Alessandro Chinellato, et al. · Journal of Clinical Psychopharmacology · 7
Benefit of statins in daily practice? A six-year retrospective observational study
2009 · P. Deambrosis, G. Terrazzani, et al. · Pharmacological Research · 7
A narrative review on the environmental impact of medicines: from water analysis and in vivo studies to prescribing appropriateness, based on European and Italian legal frameworks
2025 · Irene Cristini, Elisabetta Poluzzi, et al. · Frontiers in Drug Safety and Regulation · 5
PDF
Real-practice thromboprophylaxis in atrial fibrillation
2017 · Paola Deambrosis, Alessandra Bettiol, et al. · Acta Pharmaceutica · 4
PDF
Cost-of-Illness Study of Diabetes Mellitus: Focus on Patients with Type 2 Diabetes
2016 · Roberta Pirolo, Alessandra Bettiol, et al. · Global & Regional Health Technology Assessment · 4
PDF
Dieci anni di utilizzo delle statine: adesione alla terapia e costi del trattamento farmacologico
2005 · P. Deambrosis, C. Saramin, et al. · PharmacoEconomics Italian Research Articles · 4
Thromboprophylaxis in patients with atrial fibrillation: a real practice analysis
2016 · Paola Deambrosis, Alessandra Bettiol, et al. · Global & Regional Health Technology Assessment · 3
Il costo del paziente depresso: l’esperienza della Ulss 9 di Treviso
2007 · P. Deambrosis, G. Terrazzani, et al. · PharmacoEconomics Italian Research Articles · 3
The future of drugs distribution in the National Health System
2024 · Massimo Medaglia, Giuliano Buzzetti, et al. · Global & Regional Health Technology Assessment · 1
PDF
Prevalence, Costs and Consequences of “Manovra AIFA” for ICS-LABA Treatment in Patients with Asthma or COPD: A Real-Practice Analysis
2016 · Alessandra Bettiol, Jenny Bolcato, et al. · Global & Regional Health Technology Assessment · 1
PDF
Thromboprophylaxis in Patients with Atrial Fibrillation: A Real Practice Analysis
2016 · Paola Deambrosis, Alessandra Bettiol, et al. · Global & Regional Health Technology Assessment · 1
The Impact of Innovative Biologic Drugs in the Management of Psoriatic Patients
2015 · Alessandra Bettiol, Roberta Pirolo, et al. · 1
Thromboprophylaxis in Patients with Atrial Fibrillation: A Real Practice Analysis
2018 · Paola Deambrosis, Alessandra Bettiol, et al. · Global & Regional Health Technology Assessment
PDF
Thromboprophylaxis in patients with Atrial Fibrillation in the real practice
2018 · Paola Deambrosis · Padua@research (University of Padova)
PDF
Mo-P1:91 Predictors of hospitalization for cardiovascular disease in a hypercholesterolemic population
2006 · C. Saramin, P. Deambrosis, et al. · Atherosclerosis Supplements
Mo-P5:345 Cost of pharmacological treatment with statins
2006 · P. Deambrosis, C. Saramin, et al. · Atherosclerosis Supplements
Mo-P1:8 Evaluation of cholesterol levels and predictors of goal achievement in a hypercholesterolemic population
2006 · P. Deambrosis, C. Saramin, et al. · Atherosclerosis Supplements
Works count: 27
Citation count: 216
H-index: 7
I10-index: 5
Year
Topic
Type